Given that the enhanced expression of GluN2B might prevent memory decline during neurodegenerative diseases and aging55, 56, further characterization of the role of AC6 in regulating CREB/GluN2B-dependent memory might provide a novel approach for the development of therapeutic interventions for neurodegenerative diseases. The gene discussed is GRIN2B; the disease is neurodegenerative disease.